The emergence of a new type of head and neck cancer has exploded in the last 15 years, affecting younger males predominantly without the traditional and historic risk factors; the culprit, the Human papillomavirus (HPV). What are the implications to dentistry and how should our oral cancer screening be adjusted to compensate for this new profile?
The emergence of a new type of head and neck cancer has exploded in the last 15 years, affecting younger males predominantly without the traditional and historic risk factors; the culprit, the Human papillomavirus (HPV). According to the CDC, nearly all sexually active adults will have an HPV infection in their lifetime. This is fueling an escalating rise in the incidence of HPV-positive oropharyngeal cancer. The historic etiologic patterns related to exposure to alcohol and tobacco are declining, while HPV is becoming increasingly more common. Emerging trends had predicted that HPV-related oropharyngeal cancer would surpass the leading HPV-related cervical cancer by the year 2020. Recent collection of data from national registries has now confirmed that HPV-related oropharyngeal cancer became the leading HPV-associated cancer in 2015.
What are the implications to dentistry and how should our oral cancer screening be adjusted to compensate for this new profile? With an affinity for lymphoid tissue in areas that are often visually impeded, it is critical that we perform proper and thorough extraoral palpation and understand the subtle and often life-saving symptoms that accompany this disease. There are many questions arising due to this escalation. How is the virus transmitted and once an infection becomes active, will it ever go away? How does an infection transform into a malignancy? Who is at risk?
All of these questions and many more will be answered in a frank, open discussion complemented by a guided visual gallery of HPV lesions. High risk extraoral and intraoral anatomical areas will be reviewed as well as identifying the subtle life-saving signs that accompany HPV-related oropharyngeal cancer that are so often overlooked.
Today’s dental professional needs to be informed and be pro-active. This requires the knowledge, the skill-set and the educational resources to effectively address this changing profile in clinical practice. Join Jo-Anne Jones, 2020 Dentistry Today CE Leader and recipient of the PennWell Award for “The Most Important Dental Story Published” written on this subject for a presentation that will change the way you screen for oral cancer forever.
- Understand critical statistical information regarding oral and oropharyngeal cancer that every dental professional needs to know
- Recognize the transformation pathway of HPV into a malignancy
- Recognize the critical components of a comprehensive extraoral and intraoral examination and the life-saving subtle symptoms
- Identify the dental professional’s role in early discovery of mucosal tissue changes and potentially life-saving outcome through screening methods
- Be equipped with clinical and educational resources for your dental practice
About the Presenter:
As a successful entrepreneur and international, award winning speaker, Jo-Anne brings life, energy and inspiration to all her presentations. Jo-Anne’s no-nonsense approach and dynamic speaking style that has made her one of North America’s most sought-after lecturers in the dental community. Jo-Anne has been selected as one of DPR's Top 25 Women in Dentistry and joins the 2020 Dentistry Today CE Leaders for the 10th consecutive year. A frank and open lecture style, a focus on translation of knowledge direct to practice complemented by the provision of educational and clinical resources has earned Jo-Anne many loyal followers both nationally and internationally.
“Highly authoritative content—Jo-Anne Jones presents the alarming epidemiology of HPV-related oropharyngeal cancer as comprehensively as top scientists in the field and in a way clinicians can understand readily. This disease pattern will change the way we view oral cancer screening in practice. Jo-Anne equips clinicians to understand what they can do now to best serve their patients as continuing research helps us to further understand possible strategies for better risk-based screening and earlier detection.” Emily Utoft Durand, RDH, RF Regional Coordinator, National Dental Practice-Based Research Network
“I have had the honor of working with Jo Anne Jones RDH for almost 10 years. Jo Anne has the unique ability to provide programs that are not only highly emotional and engaging, but that are also motivational. The programs ensure participants take action and become part of the change to find oral disease at the earliest possible stage. She is a true pioneer. Her material is always the most current and well researched of any speaker I have seen on the topic of Oral Cancer. Her program is a must see for any dental healthcare provider.” Wayne Rees, Senior VP, LED Dental Inc.
Book Jo-Anne for your event:
Contact Jo-Anne for a complete list of speaking topics and further information. 905•719•4166 or by email.